Enhancing the way immune cells respond to a threat

VIB researchers uncover a metabolic switch that allows immune cells to enhance their protective function.

Immune cells protect our body against external (bacteria, viruses) and internal (cancer) threats. Among these cells, cytotoxic— or killer—T cells can rapidly activate to attack the infected or cancerous cells. They also acquire a long-term memory that helps them fight recurring infections or tumors. In each of these different stages, T cells rely on different nutrients—in other words, their metabolism changes. The team of Prof. Sarah-Maria Fendt (VIB-KU Leuven Center for Cancer Biology) identified a metabolic switch that allows these T cells to enhance their protective function. Their work appears in Cell Reports. 

In short: 

  • To respond to bacteria, viruses, or tumors, killer T cells must differentiate to an 'effector' state that allows them to attack the threat. 
  • Single-cell RNA sequencing shows that the metabolic protein asparagine synthetase (ASNS) is crucial for attaining this effector state. 
  • Overexpressing ASNS in mouse T cells increased their ability to respond to viral infection and fight skin cancer. 

The link between T cell metabolism and function 

Cytotoxic T cells play the role of soldiers in our immune system. Like all soldiers, they require training, deployment, and nutritious food. The process by which these cells take up nutrients from their environment and use them to support their function is known as cellular metabolism. ​ However, the details of how cellular metabolism supports T-cell responses are not entirely known. Scientists have some good clues, though. For example, as T cells evolve through different states during an immune response, they will use different nutrients. This is called metabolic rewiring—the nutritional needs are not the same for resting, effector, and memory T cells. 

Prof. Sarah-Maria Fendt (VIB-KU Leuven Center for Cancer Biology): "Despite our knowledge of T-cell metabolism at different functional states, little is known about how it dynamically evolves when transitioning between them. With single-cell RNA-sequencing, we can now provide a global description of this dynamic metabolic rewiring, and use it to define yet unknown metabolic dependencies of T cells." 

With single-cell RNA sequencing, Prof. Sarah-Maria Fendt's team investigated gene activity at the single-cell level. They identified how different metabolic genes dynamically evolve during T-cell responses. A metabolic requirement for an effective immune response is the expression of the metabolic protein asparagine synthetase (ASNS). 

Sarah-Maria Fendt & Juan Fernández-Garcia

Metabolically boosting T-cell fitness 

To see whether ASNS actually plays a role in living organisms, the researchers overexpressed the protein in T cells from donor mice. Recipient mice injected with T cells with higher ASNS expression were better able to respond to a viral infection, and they also showed a better anti-tumor response when dealing with melanoma. 

Dr. Juan Fernández-García, first author of the study: "Increasing ASNS expression in T cells enhanced the ability of the mice to respond to a viral infection and to clear melanoma tumors. This suggests that ASNS is an interesting protein to be overexpressed in CAR-T cells for cancer immunotherapy. Importantly, our work provides a global resource that can be used by other researchers to identify new metabolic targets to improve T-cell fitness." 

Publication 

CD8+ T Cell Metabolic Rewiring Defined by scRNA-Seq Identifies a Critical Role of ASNS Expression Dynamics in T Cell Differentiation. Fernández-García et al. Cell Reports 41, 111639, 2022. 


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

Share

Latest stories

Website preview
New research brings personalized treatment for Parkinson’s disease a step closer
Leuven, 5 May 2026 – A new study led by researchers from VIB and KU Leuven shows that Parkinson’s disease can be divided into distinct subtypes, helping explain why a single treatment does not work for all patients. Using an machine-learning-driven analysis, the team identified two main groups and five subgroups of the disease, marking an important step toward more personalized therapies. The findings were recently published in Nature Communications.
press.vib.be
Website preview
New lung cancer model reveals how tumor location shapes the immune response
Brussels, 27 April 2026 – Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By combining a patient-relevant mouse model with single-cell technologies, the team provides one of the most comprehensive immune maps to date of lung adenocarcinoma, which is the most common subtype of lung cancer. Their work appears in Nature Communications.
press.vib.be
Website preview
Molecular keyhole sheds light on pain and epilepsy
Leuven, 21 April 2026 – Researchers at VIB, VUB, and KU Leuven have identified a tiny binding site, a molecular ’keyhole’, in the TRPM3 ion channel, a crucial sensor in pain signaling. TRPM3 is also linked to rare neurodevelopmental disorders and epilepsy. In a recent study published in Nature Communications, the researchers found that even the slightest change in this keyhole can radically switch the channel’s behavior, explaining how certain mutations can flip the effects of drugs.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be